The control group was a heterogeneous patient population with a variety of infertility disease processes including uterine factor, anovulatory infertility, and tubal factor, each of which could have their own pathogenic process, some perhaps including aneuploidy
Reduced folate/ThDP exchanger SLC19A1, demonstrating decreased transcript levels 1 month after the bypass, shares the cluster (3 g) with mitochondrial ThDP transporter SLC25A19, ThTPase and BCKDHA (Figure 5A)
KLOW Injection Quick Facts Route Subcutaneous, 20 units (0.2 mL) per injection In the Vial BPC-157, GHK-Cu, KPV, TB-500 at 3/10/3/3 mg per mL Placement As close to the injury site as possible, still rotating Schedule Monday through Friday, weekends off Cycle 6 weeks on, then 6 weeks off before restarting Storage Refrigerated 36-46F, upright, do not freeze KLOW Is Four Peptides in One Vial Where to inject KLOW comes with an instruction most of the PeRx catalog does not carry: put it as close to the injury site as possible
Most side effects resolve within a few hours to a few days
Each 4ml serving contains 600mg of glutathione for maximum absorption and effectiveness
